These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26539253)

  • 1. DNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemia.
    Božić T; Lin Q; Frobel J; Wilop S; Hoffmann M; Müller-Tidow C; Brümmendorf TH; Jost E; Wagner W
    Clin Epigenetics; 2015; 7():116. PubMed ID: 26539253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Aging Signatures Are Coherently Modified in Cancer.
    Lin Q; Wagner W
    PLoS Genet; 2015 Jun; 11(6):e1005334. PubMed ID: 26110659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
    Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
    Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do age-associated DNA methylation changes increase the risk of malignant transformation?
    Wagner W; Weidner CI; Lin Q
    Bioessays; 2015 Jan; 37(1):20-4. PubMed ID: 25303747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Scoring System for Risk Assessment of Elderly Patients With Cytogenetically Normal Acute Myeloid Leukemia Based on Expression of Three AQP1 DNA Methylation-Associated Genes.
    Yin X; Huang H; Huang S; Xu A; Fan F; Luo S; Yan H; Chen L; Sun C; Hu Y
    Front Oncol; 2020; 10():566. PubMed ID: 32373535
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylation-independent
    Ma BB; Zhang TJ; Wang CZ; Xu ZJ; Zhou JD; Gu Y; Ma JC; Deng ZQ; Lin J; Qian J
    Am J Transl Res; 2020; 12(9):4840-4852. PubMed ID: 33042393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of prognostic methylation markers by methylC-capture sequencing in acute myeloid leukemia.
    Li Y; Zhao H; Xu Q; Lv N; Jing Y; Wang L; Wang X; Guo J; Zhou L; Liu J; Chen G; Chen C; Li Y; Yu L
    Oncotarget; 2017 Dec; 8(66):110444-110459. PubMed ID: 29299160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics Analysis to Determine Prognostic Mutations of 72 de novo Acute Myeloid Leukemia Cases from the Cancer Genome Atlas (TCGA) with 23 Most Common Mutations and no Abnormal Cytogenetics.
    Welsh KJ; Nedelcu E; Wahed A; Bai Y; Dasgupta A; Nguyen A
    Ann Clin Lab Sci; 2015; 45(5):515-21. PubMed ID: 26586702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia.
    Fu L; Shi J; Hu K; Wang J; Wang W; Ke X
    Oncotarget; 2015 Apr; 6(10):8144-54. PubMed ID: 25924238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of ACTL10 in Cytogenetic Normal Acute Myeloid Leukemia.
    Lai R; Zhang W; He X; Liao X; Liu X; Fu W; Yang P; Wang J; Hu K; Yuan X; Zhang X; Jing H; Liu W
    J Cancer; 2020; 11(17):5150-5161. PubMed ID: 32742462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis.
    Hong C; Yang S; Wang Q; Zhang S; Wu W; Chen J; Zhong D; Li M; Li L; Li J; Yu H; Chen H; Zeng Q; Zhang C
    Front Genet; 2021; 12():563051. PubMed ID: 33815458
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
    Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
    Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation age is associated with mortality in a longitudinal Danish twin study.
    Christiansen L; Lenart A; Tan Q; Vaupel JW; Aviv A; McGue M; Christensen K
    Aging Cell; 2016 Feb; 15(1):149-54. PubMed ID: 26594032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Array-based DNA methylation profiling in acute myeloid leukaemia.
    Wilop S; Fernandez AF; Jost E; Herman JG; Brümmendorf TH; Esteller M; Galm O
    Br J Haematol; 2011 Oct; 155(1):65-72. PubMed ID: 21790528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
    Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
    Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic biomarker to support classification into pluripotent and non-pluripotent cells.
    Lenz M; Goetzke R; Schenk A; Schubert C; Veeck J; Hemeda H; Koschmieder S; Zenke M; Schuppert A; Wagner W
    Sci Rep; 2015 Mar; 5():8973. PubMed ID: 25754700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy.
    Hiller JK; Schmoor C; Gaidzik VI; Schmidt-Salzmann C; Yalcin A; Abdelkarim M; Blagitko-Dorfs N; Döhner K; Bullinger L; Duyster J; Lübbert M; Hackanson B
    Ann Hematol; 2017 Apr; 96(4):559-565. PubMed ID: 28058491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
    Shi JL; Fu L; Wang WD
    Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.